RARE

Ultragenyx Pharmaceutical Inc.

49.73 USD
+0.25 (+0.51%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Ultragenyx Pharmaceutical Inc. stock is up 10.58% since 30 days ago. The next earnings date is May 2, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 63.64% of the previous 10 February’s closed higher than January. In the last 5 Unusual Options Trades, there were 5 CALLs. 67% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
09 Jan 20:35 16 Aug, 2024 60.00 CALL 124 2
19 Jan 19:45 17 May, 2024 60.00 CALL 429 30
19 Jan 19:45 17 May, 2024 60.00 CALL 318 30
19 Jan 19:45 19 Jul, 2024 50.00 CALL 57 0
08 Feb 19:25 17 May, 2024 25.00 CALL 12 12

About Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc. focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the. treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia.

  • Wedbush
    Fri Feb 16, 08:53
    hold
    confirm
  • Cantor Fitzgerald
    Thu Feb 15, 09:12
    buy
    confirm
  • Baird
    Tue Jan 30, 13:39
    buy
    confirm